Testing effectiveness (Phase 2)Ended earlyNCT00859495What this trial is testingTrimodal Lung-Sparing Treatment of Pleural MesotheliomaWho this might be right forPleural Mesothelioma Columbia University 9
Testing effectiveness (Phase 2)Study completedNCT00458913What this trial is testingBortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant MesotheliomaWho this might be right forMalignant Mesothelioma European Organisation for Research and Treatment of Cancer - EORTC 82
Early research (Phase 1)Study completedNCT01655225What this trial is testingLY3023414 in Participants With Advanced CancerWho this might be right forAdvanced CancerMetastatic CancerNon-Hodgkin's Lymphoma+3 more Eli Lilly and Company 156
Not applicableStudy completedNCT02585362What this trial is testingWhey Protein Supplement in Combination With Physical Exercise and Nutrition ProgramWho this might be right forLung CancerGastro-Intestinal CancerBreast Cancer+5 more Kantonsspital Winterthur KSW 52
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)UnknownNCT01569919What this trial is testingA Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural MesotheliomaWho this might be right forMalignantPleuralMesothelioma Wales Cancer Trials Unit 26
Testing effectiveness (Phase 2)Study completedNCT00154388What this trial is testingPhase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesWho this might be right forLife Threatening Diseases Novartis Pharmaceuticals 185
Early research (Phase 1)Active Not RecruitingNCT04491942What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerWho this might be right forAdvanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)UnknownNCT03475953What this trial is testingA Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsWho this might be right forColorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more Institut Bergonié 747
Testing effectiveness (Phase 2)Ended earlyNCT01861301What this trial is testingTivantinib in Treating Patients With Previously Treated Malignant MesotheliomaWho this might be right forEpithelioid MesotheliomaRecurrent Malignant MesotheliomaSarcomatoid Mesothelioma+3 more National Cancer Institute (NCI) 18
Not applicableStudy completedNCT00897247What this trial is testingBiomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or VermiculiteWho this might be right forMalignant MesotheliomaPulmonary Complications Barbara Ann Karmanos Cancer Institute 494
Not applicableWithdrawnNCT01325753What this trial is testingCryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the BodyWho this might be right forAdvanced Malignant MesotheliomaExtensive Stage Small Cell Lung CancerLung Metastases+4 more Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Ended earlyNCT03233724What this trial is testingOral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal CarcinomasWho this might be right forCarcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT00020124What this trial is testingInhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the LungsWho this might be right forLung CancerMalignant MesotheliomaMetastatic Cancer National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT00372840What this trial is testingPrinted Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+4 more Fox Chase Cancer Center 340
Large-scale testing (Phase 3)Study completedNCT02709512What this trial is testingPh 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and CisplatinWho this might be right forMesothelioma Polaris Group 249
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)UnknownNCT03852823What this trial is testingStudy of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced TumoursWho this might be right forAdvanced Solid TumoursCervical CancerMalignant Mesothelioma+2 more CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 192
Testing effectiveness (Phase 2)Study completedNCT02347917What this trial is testingBBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural MesotheliomaNon-Small Cell Lung Cancer Sumitomo Pharma Co., Ltd. 28
Testing effectiveness (Phase 2)Study completedNCT04115111What this trial is testingDiadem to Investigate the Activity and Safety of DurvalumabWho this might be right forPleura Mesothelioma Mario Negri Institute for Pharmacological Research 57